Skip to main content

IDEAYA Biosciences, Inc.

IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001676725

In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in IDEAYA Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
144
+6 vs. Q2 2023
Shares held
59.7M
+3.11M (+5.5%) vs. Q2 2023
Total value
$1.61B
+$281.0M (+21.1%) vs. Q2 2023
New holders
18
63 more added
Sold out
12
41 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 144 institutions
Q1 2021: 89 institutionsQ2 2021: 84 institutionsQ3 2021: 91 institutionsQ4 2021: 110 institutionsQ1 2022: 103 institutionsQ2 2022: 96 institutionsQ3 2022: 112 institutionsQ4 2022: 117 institutionsQ1 2023: 128 institutionsQ2 2023: 138 institutionsQ3 2023: 144 institutionsQ4 2023: 157 institutionsQ1 2024: 204 institutionsQ2 2024: 199 institutionsQ3 2024: 209 institutionsQ4 2024: 206 institutionsQ1 2025: 207 institutionsQ2 2025: 204 institutionsQ3 2025: 224 institutionsQ4 2025: 246 institutionsQ1 2026: 254 institutionsQ2 2026: 285 institutions
Value heldQ3 2023: $1.61B
Q1 2021: $558.6MQ2 2021: $533.4MQ3 2021: $837.9MQ4 2021: $820.7MQ1 2022: $392.9MQ2 2022: $489.0MQ3 2022: $667.1MQ4 2022: $835.0MQ1 2023: $625.4MQ2 2023: $1.33BQ3 2023: $1.61BQ4 2023: $2.35BQ1 2024: $3.47BQ2 2024: $2.90BQ3 2024: $2.91BQ4 2024: $2.36BQ1 2025: $1.54BQ2 2025: $2.04BQ3 2025: $2.56BQ4 2025: $3.32BQ1 2026: $3.16BQ2 2026: $3.80B
Institutions holding IDYA and their total value by quarter
QuarterHoldersValue
Q2 2026285$3.80B
Q1 2026254$3.16B
Q4 2025246$3.32B
Q3 2025224$2.56B
Q2 2025204$2.04B
Q1 2025207$1.54B
Q4 2024206$2.36B
Q3 2024209$2.91B
Q2 2024199$2.90B
Q1 2024204$3.47B
Q4 2023157$2.35B
Q3 2023144$1.61B
Q2 2023138$1.33B
Q1 2023128$625.4M
Q4 2022117$835.0M
Q3 2022112$667.1M
Q2 202296$489.0M
Q1 2022103$392.9M
Q4 2021110$820.7M
Q3 202191$837.9M
Q2 202184$533.4M
Q1 202189$558.6M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q2 2023.

Institutions holding IDYA in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Morgan Stanley232,776$6.28M0.00%−119,790−34.0%Reduced
Woodline Partners LP240,428$6.49M0.08%+63,404+35.8%Added
UBS Asset Management Americas Inc270,391$7.30M0.00%+270,391New
Ameriprise Financial Inc273,473$7.38M0.00%+31,312+12.9%Added
Invesco Ltd.290,267$7.83M0.00%+61,157+26.7%Added
Voya Investment Management LLC291,076$7.85M0.01%+6,849+2.4%Added
Opaleye Management Inc.311,500$8.40M2.76%−103,500−24.9%Reduced
Eventide Asset Management, LLC335,000$9.04M0.16%+335,000New
AXA S.A.343,755$9.27M0.03%−1,206−0.3%Reduced
Ensign Peak Advisors, Inc363,784$9.81M0.02%+130,350+55.8%Added
Goldman Sachs Group Inc420,022$11.3M0.00%+29,943+7.7%Added
Candriam Luxembourg S.C.A.430,019$11.6M0.09%+19,999+4.9%Added
D. E. Shaw & Co., Inc.436,358$11.8M0.02%+223,143+104.7%Added
Charles Schwab Investment Management Inc437,356$11.8M0.00%+291,240+199.3%Added
DAFNA Capital Management LLC499,820$13.5M4.19%+20,000+4.2%Added
Nuveen Asset Management, LLC546,260$14.7M0.01%−21,228−3.7%Reduced
Northern Trust Corp561,368$15.1M0.00%+19,380+3.6%Added
Boone Capital Management LLC570,682$15.4M4.86%+74,249+15.0%Added
First Manhattan Co593,065$16.0M0.06%00.0%Unchanged
Cormorant Asset Management, LP600,000$16.2M0.94%00.0%Unchanged
Driehaus Capital Management LLC697,461$18.8M0.24%+435,025+165.8%Added
Citadel Advisors LLC745,100$20.1M0.02%−408,329−35.4%Reduced
Platinum Investment Management Ltd766,682$20.7M0.81%−47,988−5.9%Reduced
Commodore Capital LP775,000$20.9M2.44%00.0%Unchanged
Holocene Advisors, LP1,032,931$27.9M0.12%+1,032,931New
Sofinnova Investments, Inc.1,037,187$28.0M1.94%+372,441+56.0%Added
Baker Bros. Advisors LP1,062,123$28.7M0.17%00.0%Unchanged
FMR LLC1,097,241$29.6M0.00%+3430.0%Added
Dimensional Fund Advisors LP1,142,242$30.8M0.01%+55,893+5.1%Added
Geode Capital Management, LLC1,161,105$31.3M0.00%+138,352+13.5%Added
Capital Research Global Investors1,376,870$37.1M0.01%+653,068+90.2%Added
Janus Henderson Group PLC1,723,160$46.5M0.03%+55,637+3.3%Added
Avidity Partners Management LP2,144,971$57.9M2.33%−840,729−28.2%Reduced
State Street Corp2,147,500$57.9M0.00%+8,997+0.4%Added
Boxer Capital, LLC2,202,812$59.4M3.16%00.0%Unchanged
Logos Global Management LP2,250,000$60.7M8.66%+500,000+28.6%Added
Deerfield Management Company, L.P. (Series C)2,268,628$61.2M1.35%00.0%Unchanged
Adage Capital Partners GP, L.L.C.2,286,961$61.7M0.14%−288,149−11.2%Reduced
Canaan Partners X LLC2,660,713$71.8M96.06%00.0%Unchanged
Vanguard Group Inc2,971,497$80.2M0.00%+141,844+5.0%Added
Price T Rowe Associates Inc3,030,369$81.8M0.01%+527,696+21.1%Added
Federated Hermes, Inc.3,383,729$91.3M0.24%−5,969−0.2%Reduced
BlackRock Inc.4,593,573$123.9M0.00%+237,877+5.5%Added
BVF Inc5,283,489$142.5M3.84%−400,000−7.0%Reduced
Ergoteles LLC0$00.00%−40,807−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−9,486−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−9,417−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−5,890−100.0%Sold out
Tucker Asset Management LLC0$00.00%−2,813−100.0%Sold out
Acadian Asset Management LLC0$00.00%−2,308−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,498−100.0%Sold out
Group One Trading, L.P.0$00.00%−720−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−300−100.0%Sold out
C M Bidwell & Associates Ltd0$00.00%−100−100.0%Sold out
Cutler Group LP0$00.00%−100−100.0%Sold out
Impact Partnership Wealth, LLC0$00.00%−76−100.0%Sold out